We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Shareholder support for demands of campaign group Follow This more than doubles
Activists attack influential investor group for voting against calls for deeper emissions cuts at oil company
Bramson wasted money on his ticket to ride out a governance fight
Sherborne Investors sells out after failing to oust chief executive and shrink the investment bank
Emmanuel Faber points to ‘previous leaders’ wanting ‘to regain more clout’
Cinema chain’s controversial stock-based award has raised investor ire
UK drugmaker stands by payout based on ‘absence of any findings of personal wrongdoing’ in US opioid case
UK supermarket to ‘broaden public commitments’ after prospect of shareholder vote
Billionaire investor admits surprise at economic rebound as group reports $12bn quarterly profit
Bank’s directors meet ahead of potentially embarrassing shareholder revolt at AGM
More than a quarter of miner and commodity trader’s shareholders vote against remuneration policy
Shareholders voice discontent weeks after group revealed hefty expenses tied to Refinitiv deal
Pandemic has led to greater scrutiny of awards with more companies considering restricted stock plans
Big investors target Andreas Gottschling in wake of Archegos and Greensill controversies
Asset managers urge UK companies to show restraint over executive packages for 2020
New activist shareholder may not have quick answers to drugmaker’s underlying problems
Shareholder unrest increases over plans to hand extra £2m to head of UK’s largest defence contractor
Shareholder adviser ISS urges investors to withhold support for compensation committee
It has quietly built up a multibillion-dollar stake in the struggling drugmaker
Investors should reject Larry Culp’s revised pay deal, ISS, Glass Lewis say in latest critical recommendations
Activist may focus on what UK drugmaker will look like after spinout of consumer heath business
Activist group’s investment comes as UK drugmaker’s performance lags behind rivals
Proxy adviser Glass Lewis advises rejection of remuneration policy and climate resolution
Trading volumes multiply as investor activism spreads to the region
London-based investor seeks to replace 3 members of real estate lender’s supervisory board
International Edition
